Related Experiment Video
Updated: Jan 16, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Optimal Therapeutic Strategy for Ventricular Septal Defect Closure in Extremely Preterm Infants with Chronic Lung
Akari Sato1, Mai Sekine1, Hidenori Kawasaki1
1Department of Pediatrics, Saitama Medical Center, Saitama Medical University.
Insights
Pulmonary artery banding followed by VSD closure is a viable strategy for preterm infants with severe congenital heart defects and lung disease. This approach may prevent pulmonary hypertension crises after surgery.
Area of Science:
- Pediatric Cardiology
- Neonatology
- Congenital Heart Surgery
Background:
- Preterm infants with large ventricular septal defects (VSD), severe chronic lung disease (CLD), and pulmonary hypertension (PH) face hemodynamic instability after open-heart surgery.
- Clinical decision-making regarding initial pulmonary artery banding versus one-stage VSD closure is challenging due to a lack of established guidelines for this unique population.
Purpose of the Study:
- To report a successful case of pulmonary artery banding followed by VSD closure in an extremely preterm infant.
- To review existing literature on managing VSD with CLD and PH in preterm infants.
Main Methods:
- A case report of a preterm infant (23 weeks 4 days gestation, 540 g) with VSD, CLD, and PH treated with initial pulmonary artery banding and subsequent VSD closure.
- Literature review of similar cases in preterm infants with VSD, CLD, and PH.
Main Results:
- The infant successfully underwent pulmonary artery banding and later VSD closure, with pre-banding hemodynamics showing a pulmonary-to-systemic blood flow ratio of 2.5 and pulmonary vascular resistance of 2.6 U·m².
- Literature search identified five infants (including this case) with VSD, CLD, and PH; one underwent banding first and survived, while three underwent one-stage VSD closure with one mortality due to postoperative PH crisis.
- Three of the five reviewed infants required tracheostomy.
Conclusions:
- The choice between initial pulmonary artery banding and one-stage VSD closure requires careful case-by-case evaluation, considering the severity of VSD, CLD, and PH.
- Further registry studies are necessary to clarify the outcomes of these two surgical strategies in this high-risk population.
Abstract:
In preterm infants with large ventricular septal defects (VSD), severe chronic lung disease (CLD), and pulmonary hypertension (PH), hemodynamic instability may occur after open-heart surgery. The selection of first pulmonary artery banding or one stage VSD closure is a clinical issue. At present, no guidelines exist to support decision-making in this unique population. This study reports the case of a preterm infant with a gestational age of 23 weeks and 4 days, a birth weight of 540 g, and elevated immunoglobulin-M levels, who was successfully treated with pulmonary artery banding and subsequently VSD closure. Before pulmonary artery banding, the pulmonary-to-systemic blood flow ratio was 2.5 and pulmonary vascular resistance was 2.6 U·m2 under general anesthesia with FiO2 = 0.6. However, pulmonary artery banding preceded considering the severe CLD and the risk of PH crisis after cardiopulmonary bypass. In a review of the literature on preterm infants with VSD with CLD and PH, only five infants, including the one in this case, were found. One infant underwent pulmonary artery banding first and survived, and three infants underwent one-stage VSD closure, after which one died (trisomy 21) due to a postoperative PH crisis. Three of the five cases underwent tracheostomy. The selection of first pulmonary artery banding or one-stage VSD closure needs to be carefully considered on a case-by-case basis, taking into consideration the severity of the VSD with CLD and PH. A future registry study will be needed to review these cases and clarify the outcome of the two strategies.
Related Concept Videos
Mitral Stenosis III: Medical Management
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Aortic Regurgitation III: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

